Like, uh, I mean, this is, this is the health of our population
Experimental and clinical studies with long-acting GLP-1R agonists or unimolecular peptides that simultaneously target GLP-1R and GIPR have shown marked anti-hyperglycemic effects and weight reduction (1113)
Of the many lawsuits against the manufacturer, several allege that using the drug resulted in the following medical issues: Vision loss or changes Gastroparesis (stomach paralysis) Neuropathy with gastroparesis Intestinal blockage (often requiring surgery to repair) Cyclical vomiting Pancreatic cancer Necrotizing pancreatitis Esophageal injury with surgery Blood clots Has Mounjaro Harmed You
These findings positioned DHODH as a third axis of ferroptosis defense, alongside GPX4 and FSP1, particularly in mitochondria-rich or metabolically active cell types
President Trump upon taking office reversed the Biden administrations plan to expand Medicare coverage by including GLP-1s for weight loss
As a direct lipolytic, it targets adipocytes directly, leading to their elimination